Abstract

Childhood cancer is a rare but leading cause of morbidity and mortality. Established risk factors, accounting for <10% of incidence, have been identified primarily from case-control studies. However, recall, selection and other potential biases impact interpretations particularly, for modest associations. A consortium of pregnancy and birth cohorts (I4C) was established to utilise prospective, pre-diagnostic exposure assessments and biological samples. Eligibility criteria, follow-up methods and identification of paediatric cancer cases are described for cohorts currently participating or planning future participation. Also described are exposure assessments, harmonisation methods, biological samples potentially available for I4C research, the role of the I4C data and biospecimen coordinating centres and statistical approaches used in the pooled analyses. Currently, six cohorts recruited over six decades (1950s-2000s) contribute data on 388120 mother-child pairs. Nine new cohorts from seven countries are anticipated to contribute data on 627500 additional projected mother-child pairs within 5years. Harmonised data currently includes over 20 "core" variables, with notable variability in mother/child characteristics within and across cohorts, reflecting in part, secular changes in pregnancy and birth characteristics over the decades. The I4C is the first cohort consortium to have published findings on paediatric cancer using harmonised variables across six pregnancy/birth cohorts. Projected increases in sample size, expanding sources of exposure data (eg, linkages to environmental and administrative databases), incorporation of biological measures to clarify exposures and underlying molecular mechanisms and forthcoming joint efforts to complement case-control studies offer the potential for breakthroughs in paediatric cancer aetiologic research.

Highlights

  • While cancer in children and adolescents is rare worldwide, it remains a leading cause of morbidity and mortality despite notable improvements in survival.[1]

  • Calculation of person-years of follow-up are based on the start time defined as the birth date; the end time for those with cancer defined as the date of cancer diagnosis; the end time for those without cancer defined as the date the child is no longer under observation

  • The cohorts range in size from 10,625 (TIHS) to 110,000 (MoBa) motherchild pairs

Read more

Summary

Introduction

While cancer in children and adolescents is rare worldwide, it remains a leading cause of morbidity and mortality despite notable improvements in survival.[1] Established risk factors include prenatal exposure to diagnostic x-rays[2], genetic syndromes[3], and high birthweight[4]. A consortium of pregnancy and birth cohorts (I4C) was established to utilize prospective, pre-diagnostic exposure assessments and biological samples. Harmonized data currently includes 20+ ‘core’ variables, with notable variability in mother/child characteristics within and across cohorts, reflecting, in part, secular changes in pregnancy and birth characteristics over the decades. Projected increases in sample size, expanding sources of exposure data (e.g., linkages to environmental and administrative databases), incorporation of biological measures to clarify exposures and underlying molecular mechanisms, and forthcoming joint efforts to complement casecontrol studies offer the potential for breakthroughs in pediatric cancer etiologic research. Key words International Childhood Cancer Cohort Consortium (I4C); birth cohort; leukemia; childhood cancer; lifestyle factors; environmental exposures; recall bias; selection bias;

Objectives
Methods
Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.